INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 5 analysts with an average price target of $21.87. This is a potential upside of $19.4 (785.43%) from yesterday's end of day stock price of $2.47.

Inovio Pharmaceuticals's activity chart (see below) currently has 130 price targets and 129 ratings on display. The stock rating distribution of INO is 53.85% HOLD and 46.15% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.46% with an average time for these price targets to be met of 559.53 days.

Highest price target for INO is $5, Lowest price target is $3, average price target is $4.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 13-Aug-2025. First documented stock forecast 17-Jun-2014.

Currently out of the existing stock ratings of INO, 7 are a HOLD (53.85%), 6 are a BUY (46.15%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$3

$0.65 (27.66%)

$3

2 months 7 days ago
(13-Aug-2025)

3/8 (37.5%)

$1.38 (85.19%)

1200

Hold

$5

$2.65 (112.77%)

$5

5 months 7 days ago
(13-May-2025)

13/20 (65%)

$3.12 (165.96%)

417

Buy

$15

5 months 7 days ago
(13-May-2025)

2/5 (40%)

$10.92 (267.65%)

367

Buy

$15

5 months 7 days ago
(13-May-2025)

0/2 (0%)

$10.92 (267.65%)

Buy

7 months 7 days ago
(13-Mar-2025)

1/1 (100%)

$5.13 (74.67%)

67

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 559.53 days on average for the stock forecasts to be realized with a an average price target met ratio 79.46

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan has 14 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Aydin Huseynov with highest potential upside - $177.65

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?